Home » Topics » Regulatory

Regulatory
RSS

Atacand approved in Europe for treatment of chronic heart failure

Nov. 30, 2004

Combunox approved for short-term management of acute moderate/severe pain

Nov. 30, 2004

Tysabri approved for multiple sclerosis

Nov. 25, 2004

Tarceva approved for advanced NSCLC

Nov. 22, 2004

Norditropin approved for adults with severe growth hormone deficiency

Nov. 9, 2004

New approval for Eloxatin

Nov. 9, 2004

New indication for Sandostatin injection approved in Japan

Oct. 29, 2004

European approval for Emselex

Oct. 28, 2004

CHMP adopts extension of indication for Schering-Plough HCV products

Oct. 27, 2004

Lundbeck files for new Alzheimer's indication for Ebixa in Europe

Oct. 25, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...